Research at the Division of Pharmacology and Toxicology is driven by the motivation to decipher the dynamic mechanisms underlying aging and disease, such as chronic pain, cerebrovascular diseases, neurodegeneration, and rare neurodevelopmental diseases. To this end, we combine a diverse set of methods ranging from biochemistry, electrophysiology, primary cell culture and preclinical mouse models to molecular modelling and quantitative proteomics. In addition to preclinical work our translational research goals benefit from valuable collaborations with clinicians and patient communities. We strive to identify novel targets that have the potential to promote healthy aging and improve the prevention as well as treatment of aforementioned diseases.
David Gómez Varela, head of the Center of Excellence for Metaproteomics, nutritionist Karl-Heinz Wagner and pharmacologist Manuela Schmidt investigate…
Anna Weinzinger (University of Vienna) has been awarded a €999,979 Precision Medicine grant from the Vienna Science and Technology Fund (WWTF) for the…
The Weiss Award – Austria’s most prestigious privately funded research prize in anesthesiology – has been awarded this year to Simon Woyke (Medical…
From March 5-6, 2026, Assoc. Prof. Marietta Zille, PhD, together with our postdoctoral researcher Dr. Daniel Cuervo Zanatta, PhD students Amir Pasokh…
As part of a WTZ/OeAD-funded collaboration between Austria and India, we recently hosted Dr. Rambabu Reddi (Assistant Professor, IIT Kharagpur, India)…
Mit tiefer Trauer und großer Dankbarkeit nehmen wir Abschied von Universitätsprofessor Dr. Peter Heistracher, der am 19. Februar 2026 im Alter von 94…
